NIH-funded research Career grant

Creating new methods to synthesize complex chemical structures.

Official title: Methods for Enantioselective Spirocycle Synthesis and Radical Hydroamination of Trisubstituted Alkenes

Funded at California Institute of Technology · NIH-10913602 · Data updated 2026-11-12

This study is exploring new ways to create special chemical compounds that could help in making better medicines, especially for treating different health conditions.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology
NIH-funded
Lab location1 site (Pasadena, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$120,767
NIH project number5K99GM152819-02
Project IDNIH-10913602 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research are individuals with conditions that could be treated by new drugs derived from the synthesized compounds.

Less likely to help

Patients who are not affected by conditions treatable with the newly developed compounds may not receive any benefit from this research.

What this research studies

This research investigates innovative techniques for synthesizing spirocyclic compounds and performing radical hydroamination on specific alkenes. By combining experimental methods with computational analysis, the project aims to enhance the understanding of chemical reactions and improve the design of new synthetic pathways. The focus is on developing enantioselective methods that can produce complex molecules with potential medicinal properties, particularly those containing quaternary stereocenters. This could lead to the creation of new drugs or therapies that are more effective in treating various conditions.

Why it matters

Potential benefit: If successful, this research could lead to the development of new medications with improved efficacy and fewer side effects.

How similar studies have gone: Other research has shown promise in using similar synthetic methods to develop effective therapeutic agents, indicating a potential for success in this area.

Where this research is happening

  • California Institute of Technology
    Pasadena, United States
    Active

Researchers

  • Principal investigator: Ramirez, Melissa — California Institute of Technology
  • Study coordinator: Ramirez, Melissa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.